Kyntra Bio (KYNB) News
NASDAQ: KYNBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.56-0.24 (-13.33%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
KYNB news summary
We found 4 recent headlines mentioning Kyntra Bio (KYNB): 3 in the past week and 4 in the past 30 days, most often from Nasdaq, GlobeNewswire. KYNB is making an outsized move today, down 13.33% at $1.56, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Kyntra Bio (KYNB) Q3 2026 Earnings Call Transcript", was published by Nasdaq on Nov 17, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Kyntra Bio headlines
- Kyntra Bio (KYNB) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaqKYNB, HEI.A
- FibroGen, Inc. Reports Third Quarter 2026 Financial ResultsFibroGen, Inc. (operating as Kyntra Bio, Inc.) reported its financial results for the third quarter of 2026 and announced several strategic updates. The company completed a restructuring of its…NasdaqKYNB, ET
- Kyntra Bio Reports Third Quarter 2026 Financial Results and Provides Business UpdateSAN FRANCISCO, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio (Nasdaq: KYNB) today reported financial results for the third quarter 2026 and provided an update on the company’s recent developments.GlobeNewswire
- Kyntra Bio to Report Third Quarter 2026 Financial ResultsSAN FRANCISCO, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio, Inc. (Nasdaq: KYNB) will announce third quarter 2026 financial results on Monday, November 16 after market close. Kyntra Bio will also…GlobeNewswire